Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(1R)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

229639-56-9

Post Buying Request

229639-56-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

229639-56-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 229639-56-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,9,6,3 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 229639-56:
(8*2)+(7*2)+(6*9)+(5*6)+(4*3)+(3*9)+(2*5)+(1*6)=169
169 % 10 = 9
So 229639-56-9 is a valid CAS Registry Number.

229639-56-9Relevant articles and documents

New resolution approach for large-scale preparation of enantiopure didesmethylsibutramine (DDMS)

Han, Zhengxu,Krishnamurthy, Dhileepkumar,Fang, Q. Kevin,Wald, Stephen A.,Senanayake, Chris H.

, p. 3553 - 3556 (2003)

An improved synthesis and efficient resolution method to prepare both enantiopures of DDMS using crystallization of enantiomerically pure tartaric acid salts of racemic DDMS are disclosed.

PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF

-

Page/Page column 6, (2011/10/04)

Phenylcyclobutylamide derivatives and their optical isomers, the preparing processes and the uses thereof, which includes the compounds of formula (I), their pure stereoisomers and their pharmaceutically acceptable salts. In formula (I), R is H, formacyl,

PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARING PROCESSES AND THE USES THEREOF

-

Page/Page column 8, (2010/12/30)

Phenylcyclobutylamide derivatives and their optical isomers, the preparing processes and the uses thereof, which includes the compounds of formula (I), their pure stereoisomers and their pharmaceutically acceptable salts. In formula (I), R is H, formacyl,

Highly enantioselective catalytic asymmetric synthesis of a (R)-sibutramin precursor

Berens, Ulrich,Hafner, Andreas,Dosenbach, Oliver,Tritschler, Tanja,Schwarzenbach, Franz,Kirner, Hans-Jorg,Malan, Christophe,Mai-Huynh, Oanh

scheme or table, p. 59 - 64 (2010/08/22)

The first highly enantioselective, catalytic asymmetric synthesis of di-des-methylsibutramine 3 is described. Dienamide 10, prepared by acetic acid anhydride quenching of the condensation product of nitrile 4 with a methallyl magnesium chloride, proved to

A new and direct asymmetric synthesis of a hindered chiral amine via a novel sulfinate ketimine derived from N-tosyl-1,2,3-oxathiazolidme-2-oxide: Practical asymmetric synthesis of (R)-sibutramine

Han, Zhengxu,Krishnamurthy, Dhileepkumar,Senanayake, Chris H.

, p. 327 - 333 (2012/12/22)

A novel and direct approach for the asymmetric synthesis of (R)-sibutramine via chiral amine 5 using N-tosyl-1,2,3-oxathiazolidine-2-oxide (13) as a recyclable chiral auxiliary is described. Chiral sulfinate imine 16e was obtained by treatment of 13e with

DOPAMINE-AGONIST COMBINATION THERAPY FOR IMPROVING SLEEP QUALITY

-

Page/Page column 90-91, (2008/06/13)

The present invention generally to pharmaceutical compositions comprising a dopamine agonist and sedative agent. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine. In a preferred embodiment, the sedative agent is

A method of manufacturing an amine stereoisomerically

-

Page/Page column 53, (2010/02/12)

This invention provides intermediates useful in a method of preparing amine stereoisomers. It also provides a method of preparing sulfoxide and sulfinylamine stereoisomers using certain of the intermediates.

Therapeutic agents

-

, (2008/06/13)

The present invention provides a method of treating and preventing obesity and related co-morbid conditions comprising the administration of a therapeutically effective amount of one or more monoamine reuptake inhibitors which are serotonin reuptake inhibitors and/or noradrenaline reuptake inhibitors and a 5-HT1A agonist to a patient in need thereof.

First application of tunable alkyl or aryl sulfinamides to the stereoselective synthesis of a chiral amine: asymmetric synthesis of (R)-didesmethylsibutramine ((R)-DDMS) using (R)-triethylmethylsulfinamide ((R)-TESA).

Han, Zhengxu,Krishnamurthy, Dhileepkumar,Pflum, Derek,Grover, Paul,Wald, Stephen A,Senanayake, Chris H

, p. 4025 - 4028 (2007/10/03)

A highly diastereoselective addition of i-BuLi to a triethylmethylsulfinamide derived aldimine was used as the key step in the first asymmetric synthesis of (R)-didesmethylsibutramine, a metabolite of sibutramine for the potential treatment of CNS disorders. [reaction: see text]

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 229639-56-9